Actively Recruiting
Laparoscopic Pancreaticoduodenectomy
Led by Minia University · Updated on 2025-08-29
30
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Laparoscopic pancreaticoduodenectomy was first performed by Garner and Pomp in 1994. This is a technically difficult, time consuming and high rate of complication procedure. The reason is that duodenum and head of pancreas locate deeply in retroperitoneum and are surrounded by important structures such as inferior vena cava, abdominal aorta, superior mesenteric artery, superior mesenteric vein (SMV), portal vein (PV) and hepatic arteries. Injuring these structures during the surgery can lead to life-threatening complications. Moreover, doing anastomoses through laparoscopy, especially pancreatic anastomosis, is more difficult and takes more time than through open approach. The outcome of PD has improved over the last two decades due to advances in surgical techniques, anesthesia and perioperative care. Although studies from high volume centers demonstrate reduce in the operative mortality to less than 3%, the postoperative morbidity rate is still ranging from 30% to 60%. Laparoscopic surgery is being used increasingly as a less invasive alternative to traditional interventions for pancreatic resection. Laparoscopic pancreaticoduodenectomy (LPD) is a difficult procedure that has become increasingly popular. Nevertheless, comparative data on outcomes remain limited. In this prospective study, investigators evaluate the safety and feasibility of surgical and oncological outcomes of minimally invasive PD.
CONDITIONS
Official Title
Laparoscopic Pancreaticoduodenectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients meeting the curative treatment intent with no evidence of metastasis
- Radiological non-involvement of superior mesenteric vein and portal vein
- Preserved fat planes between celiac axis, hepatic artery, and superior mesenteric artery
- Patients with resectable pancreatic head cancer, cholangiocarcinoma, duodenal cancer, or ampullary tumors fit for laparoscopic pancreaticoduodenectomy
You will not qualify if you...
- Patients unfit for surgery due to severe medical illness
- Presence of distant metastases including peritoneal, liver, or distant lymph node metastases
- Irresectable tumors found during diagnostic laparoscopy
- Patients requiring left, central, or total pancreatectomy or other palliative surgery
- History of other malignant diseases
- Pregnant or breastfeeding women
- Patients with serious mental disorders
- Vascular invasion requiring vascular resection as evaluated by imaging and multidisciplinary team
- Pancreatoduodenectomy for cystic lesions, benign tumors, or chronic calcific pancreatitis
- Patients with cirrhotic liver
- Patients who refuse to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Liver and GIT hospital , Minia University
Minya, Egypt, 61519
Actively Recruiting
Research Team
S
Saleh K Saleh, MD
CONTACT
R
Rabeh K Saleh, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here